Article

Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

Max Planck Institut für Biochemie, D-82152 Martinsried, Germany.
Structure (Impact Factor: 6.79). 02/2005; 13(1):155-67. DOI: 10.1016/j.str.2004.11.009
Source: PubMed

ABSTRACT Insulin-like growth factor binding proteins (IGFBPs) control the extracellular distribution, function, and activity of IGFs. Here, we report an X-ray structure of the binary complex of IGF-I and the N-terminal domain of IGFBP-4 (NBP-4, residues 3-82) and a model of the ternary complex of IGF-I, NBP-4, and the C-terminal domain (CBP-4, residues 151-232) derived from diffraction data with weak definition of the C-terminal domain. These structures show how the IGFBPs regulate IGF signaling. Key features of the structures include (1) a disulphide bond ladder that binds to IGF and partially masks the IGF residues responsible for type 1 IGF receptor (IGF-IR) binding, (2) the high-affinity IGF-I interaction site formed by residues 39-82 in a globular fold, and (3) CBP-4 interactions. Although CBP-4 does not bind individually to either IGF-I or NBP-4, in the ternary complex, CBP-4 contacts both and also blocks the IGF-IR binding region of IGF-I.

0 Bookmarks
 · 
73 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Insulin-like growth factor-I (IGF-I) is an important growth promoting protein that is involved in numerous cellular responses and multiple biological systems. Although the molecular structure, function and recombinant production of IGF-I in various hosts have been the subject of much researches over the recent past, methods to determine the bioactivity of this protein have not been fully explored. Several assays have traditionally been used to measure IGF-I bioactivity, but have not become a routine laboratory practice due to the high cost involved and technical problems. Thus, there is still a need for a rapid, technically simple and accurate assay to determine IGF-I bioactivity. This review highlights the various cell-based assays currently commercially available for measuring the bioactivity of IGF-I along with their limitations. This is aimed at presenting the modern-day IGF researcher with a holistic overview of the current trends and future prospects regarding IGF-I bioactivity determinations.
    Growth Factors 07/2014; 32(3-4). · 3.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Insulin-like growth factor 1 and 2 (IGF1 and -2) are potent stimulators of diverse cellular activities such as differentiation and mitosis. Six IGF binding proteins (IGFBP1 through -6) are primary regulators of IGF half-life and receptor availability. Generally, the binding of IGFBPs inhibits IGF-receptor activation. However, it has been shown that IGFBP2 in complex with IGF2 (IGF2/IGFBP2) stimulates osteoblast function in vitro and increases skeletal mass in vivo. IGF2 binding to IGFBP2 greatly increases the affinity for 2- or 3-carbon O-sulphated glycosaminoglycans (GAGs), e.g., heparin and heparan sulphate, which is hypothesized to preferentially and specifically target the IGF2/IGFBP2 to the bone matrix. In order to obtain a more detailed understanding of the interactions between IGF2/IGFBP2 and GAGs, we investigated heparin binding properties of IGFBP2 and the IGF2/IGFBP2 in a quantitative manner. For this study, we mutated key positively charged residues within the two heparin binding domains (HBDs) in IGFBP2 and in one potential HBD in IGF2. Using heparin affinity chromatography, we demonstrate that the two IGFBP2 HBDs contribute differentially to GAG binding in the free IGFBP2 and the IGF2/IGFBP2 protein complex. Moreover, we identify a significant contribution from the HBD in IGF2 to the increased IGF2/IGFBP2 heparin affinity. Using molecular modeling, we present a novel model for the IGF2/IGFBP2 interaction with heparin where all three proposed HBDs constitute a positively charged and surface-exposed area that would serve to promote the increased heparin affinity of the complex compared to free intact IGFBP2.
    Journal of Molecular Endocrinology 03/2014; · 3.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We cloned and characterized cDNA sequence of insulin-like growth factor binding protein-4 (IGFBP-4) from Japanese flounder (Paralichthys olivaceus). The 1493bp full-length cDNA sequence contained an open reading frame (ORF) of 780bp, encoded a protein of 259 amino acids. The deduced amino acid sequences included a putative signal peptide of 28 amino acid residues resulting in a mature protein of 231 amino acids. Twenty cysteine residues and two conserved IGFBPs motif (GCGCCXXC and CWCV) were found in the N- and C-terminal domain. In the over 13 kbp genomic sequence, four exons, three introns, and 5'-/3'-flanking sequences were identified. Sequence alignment and phylogenetic analysis showed that Japanese flounder IGFBP-4 was indeed the ortholog of the human IGFBP-4 gene and shared high identities with other teleost IGFBP-4 genes. The promoter region was also analyzed and several potential transcription factor (TF) binding sites were determined which may modulate the IGFBP-4 expression. Quantitative real-time PCR analysis revealed that IGFBP-4 mRNA was observed in various tissues, with intestine showing the highest expression. Maternal transcripts of IGFBP-4 gene existed in the early embryonic stages and then increased in the following stages until hatching, suggesting that IGFBP-4 may be involved in the fish early development. Expression level of IGFBP-4 mRNA was relatively higher at 3days post hatching (dph) and 15dph, and gradually decreased during the metamorphosis period. All these results indicated that IGFBP-4 plays a significance role in IGF regulating vertebrate growth and development.
    Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology 06/2014; · 1.90 Impact Factor